Finch Therapeutics Group, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 0 | $1.54 | $1.54 | $1.54 |
Finch Therapeutics Group, Inc. Earnings Date And Information
Finch Therapeutics Group, Inc. last posted its earnings results on Thursday, August 10th, 2023. The company reported $-4.33 earnings per share for the quarter, topping analysts' consensus estimates of $-4.51 by $0.18. The company had revenue of 0 for the quarter and had revenue of 107,000 for the year. Finch Therapeutics Group, Inc. has generated $-47 earnings per share over the last year ($-46.59 diluted earnings per share) and currently has a price-to-earnings ratio of -1.36. Finch Therapeutics Group, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based on prior year's report dates.
Finch Therapeutics Group, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$3.01 | $0 | $0 | ||
| 05/10/2024 | Q1 2024 | -$2.41 | $0 | |||
| 04/26/2024 | Q4 2023 | -$1.89 | $2.85 M | |||
| 11/08/2023 | Q3 2023 | -$1.51 | $0 | |||
| 08/10/2023 | Q2 2023 | -$4.51 | -$4.33 | 0.18 | $0 | |
| 05/10/2023 | Q1 2023 | -$2.70 | -$39.89 | -37.19 | $107,000 | |
| 03/23/2023 | Q4 2022 | -$16.48 | $8,000 | |||
| 11/10/2022 | Q3 2022 | -$12.01 | -$25.21 | -13.2 | $750,000 | $138,000 |
| 08/11/2022 | Q2 2022 | -$13.81 | -$14.36 | -0.55 | $650,000 | $361,000 |
| 05/16/2022 | Q1 2022 | -$0.32 | -$15.50 | -15.18 | $354,000 | |
| 03/31/2022 | Q4 2021 | -$12.04 | $806,000 | |||
| 11/10/2021 | Q3 2021 | -$12.61 | -$6.29 | 6.32 | $11.34 M | |
| 08/10/2021 | Q2 2021 | -$8.41 | -$9.60 | -1.19 | $2.83 M | |
| 05/13/2021 | Q1 2021 | -$0.24 | -$29.89 | -29.65 | $3.55 M | |
| 12/30/2020 | Q4 2020 | -$46.85 | $1.81 M | |||
| 09/29/2020 | Q3 2020 | -$36.65 | $1.77 M | |||
| 06/29/2020 | Q2 2020 | -$30.71 | $2.35 M | |||
| 03/30/2020 | Q1 2020 | -$30.13 | $1.79 M |
Finch Therapeutics Group, Inc. Earnings: Frequently Asked Questions
-
When is Finch Therapeutics Group, Inc.'s earnings date?
Finch Therapeutics Group, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates.
-
Did Finch Therapeutics Group, Inc. beat their earnings estimates last quarter?
In the previous quarter, Finch Therapeutics Group, Inc. (:FNCH) reported $-4.33 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.51 by $0.18.
-
How can I listen to Finch Therapeutics Group, Inc.'s earnings conference call?
The conference call for Finch Therapeutics Group, Inc.'s latest earnings report can be listened to online.
-
How can I read Finch Therapeutics Group, Inc.'s conference call transcript?
The conference call transcript for Finch Therapeutics Group, Inc.'s latest earnings report can be read online.
-
How much revenue does Finch Therapeutics Group, Inc. generate each year?
Finch Therapeutics Group, Inc. (:FNCH) has a recorded annual revenue of $107,000.
-
How much profit does Finch Therapeutics Group, Inc. generate each year?
Finch Therapeutics Group, Inc. (:FNCH) has a recorded net income of $107,000. Finch Therapeutics Group, Inc. has generated $-46.59 earnings per share over the last four quarters.
-
What is Finch Therapeutics Group, Inc.'s price-to-earnings ratio?
Finch Therapeutics Group, Inc. (:FNCH) has a price-to-earnings ratio of -1.36 and price/earnings-to-growth ratio is -0.04.
